Article
Use of intravitreal steroid injections needs to be fully explored for safety as well as efficacy
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Q&A: Marion Munk on IntRIS symposium at EURETINA 2025
NK Insights: An Interactive Corneal Sensitivity Testing Workshop
Q&A: Giuseppe Querques on PVAC and TelCaps
3 Things You Should Know About Interventional Glaucoma Comanagement
New company OpZira formed following Alcon’s acquisition of LumiThera
SAR402663 earns fast track designation for treatment of nAMD